<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Cytopoint now licensed for pruritus associated with allergic dermatitis</title><link>/b/veterinary-news/posts/cytopoint-now-licensed-for-pruritus-associated-with-atopic-dermatitis</link><description> Zoetis has announced that the licence for Cytopoint (lokivetmab) has been extended to include the treatment of pruritus associated with allergic dermatitis in dogs. 
 Cytopoint is an injectable monoclonal antibody therapy for dogs that targets and neutralises</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>